文献速递临床试验与 GCP

低碳水化合物饮食治疗2型糖尿病(LoCaT):多中心随机对照试验研究方案

Low-carbohydrate diet in the treatment of type 2 diabetes mellitus (LoCaT): study protocol for a multicenter, randomized controlled trial.
PubMed 文献 · Trials · 2023-06-19

本研究为多中心随机对照试验,计划招募120例血糖控制不佳的2型糖尿病患者,按1:1随机分为卡格列净组和低碳水化合物饮食组,主要结局为干预3个月后糖化血红蛋白水平变化,次要结局包括范围内时间和降糖药物费用。

要点

  • 多中心随机对照试验,计划招募120例血糖控制不佳的2型糖尿病患者。
  • 按1:1随机分为卡格列净组与低碳水化合物饮食组。
  • 主要结局为3个月干预后糖化血红蛋白水平变化。

核心结论

  • 尚无既往研究比较低碳水化合物饮食与降糖药物,LoCaT试验将从多角度评估参与者代谢,研究结果被认为将优化2型糖尿病患者的治疗。

研究设计与样本

  • 多中心随机对照试验,计划招募120例血糖控制不佳的2型糖尿病患者,按1:1随机分为卡格列净组和低碳水化合物饮食组。

主要发现

  • 主要结局为3个月干预后糖化血红蛋白水平变化。
  • 次要结局为范围内时间和降糖药物费用。
  • 探索性结局包括体格检查、体成分、血糖变异性、食欲、糖脂代谢、肝脏脂质含量和尿糖阈值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Low-carbohydrate diet (LCD) is an emerging therapy for type 2 diabetes mellitus (T2DM). Although its effect on glucose control has been confirmed in previous clinical trials, most of those studies have focused on comparing calorie-restricted LCD to iso-caloric low-fat diets. In this study, we aim to compare the effects of LCD and canagliflozin, a sodium-glucose cotransporter 2 inhibitor, in patients with T2DM. METHODS: This is a multicenter, randomized controlled trial. We will recruit 120 patients with poor-controlled T2DM. Participants will be randomly divided into canagliflozin and LCD groups in a 1:1 ratio. The primary outcome is the change in hemoglobin A1C levels after the 3-month intervention. The secondary outcomes are the time in range and cost of antihyperglycemic agents. Exploratory outcomes include physical examination, body composition, glucose variability, appetite, glycolipid metabolism, liver lipid content, and urine glucose threshold. DISCUSSION: No previous study has compared an LCD with antihyperglycemic agents. In LoCaT, participants' metabolism will be assessed from multiple perspectives. It is believed that the finding obtained from this trial will optimize the treatments for patients with T2DM. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1900027592. Registered on November 20, 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Xia X, Xu M, Gu Y, et al. Low-carbohydrate diet in the treatment of type 2 diabetes mellitus (LoCaT): study protocol for a multicenter, randomized controlled trial. Trials. 2023. PMID: 37337229. doi:10.1186/s13063-023-07427-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。